1 – 11 of 11
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(33). p.20127-20138(
- Contribution to journal › Article
- 2019
-
Mark
The molecular landscape of ETMR at diagnosis and relapse
(
- Contribution to journal › Article
-
Mark
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
(
- Contribution to journal › Article
- 2016
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
(
- Contribution to journal › Article
-
Mark
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
(
- Contribution to journal › Article
- 2015
-
Mark
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
(
- Contribution to journal › Article
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
(
- Contribution to journal › Article
-
Mark
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
(
- Contribution to journal › Article
- 2014
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Signatures of mutational processes in human cancer
(
- Contribution to journal › Article